QQQ   290.39 (+0.00%)
AAPL   113.85 (-2.97%)
MSFT   210.11 (-0.13%)
FB   268.43 (-0.47%)
GOOGL   1,727.56 (-0.51%)
AMZN   3,098.39 (-0.03%)
TSLA   521.85 (+6.58%)
NVDA   525.60 (+0.40%)
BABA   270.11 (-0.23%)
CGC   24.72 (+4.22%)
GE   10.07 (+3.18%)
MU   64.18 (+4.53%)
AMD   85.31 (+0.79%)
T   28.62 (+1.06%)
NIO   55.38 (+12.45%)
F   8.86 (+1.37%)
ACB   7.18 (+0.70%)
GILD   59.89 (-0.37%)
NFLX   476.62 (-2.38%)
BA   211.53 (+5.97%)
DIS   145.98 (+3.48%)
QQQ   290.39 (+0.00%)
AAPL   113.85 (-2.97%)
MSFT   210.11 (-0.13%)
FB   268.43 (-0.47%)
GOOGL   1,727.56 (-0.51%)
AMZN   3,098.39 (-0.03%)
TSLA   521.85 (+6.58%)
NVDA   525.60 (+0.40%)
BABA   270.11 (-0.23%)
CGC   24.72 (+4.22%)
GE   10.07 (+3.18%)
MU   64.18 (+4.53%)
AMD   85.31 (+0.79%)
T   28.62 (+1.06%)
NIO   55.38 (+12.45%)
F   8.86 (+1.37%)
ACB   7.18 (+0.70%)
GILD   59.89 (-0.37%)
NFLX   476.62 (-2.38%)
BA   211.53 (+5.97%)
DIS   145.98 (+3.48%)
QQQ   290.39 (+0.00%)
AAPL   113.85 (-2.97%)
MSFT   210.11 (-0.13%)
FB   268.43 (-0.47%)
GOOGL   1,727.56 (-0.51%)
AMZN   3,098.39 (-0.03%)
TSLA   521.85 (+6.58%)
NVDA   525.60 (+0.40%)
BABA   270.11 (-0.23%)
CGC   24.72 (+4.22%)
GE   10.07 (+3.18%)
MU   64.18 (+4.53%)
AMD   85.31 (+0.79%)
T   28.62 (+1.06%)
NIO   55.38 (+12.45%)
F   8.86 (+1.37%)
ACB   7.18 (+0.70%)
GILD   59.89 (-0.37%)
NFLX   476.62 (-2.38%)
BA   211.53 (+5.97%)
DIS   145.98 (+3.48%)
QQQ   290.39 (+0.00%)
AAPL   113.85 (-2.97%)
MSFT   210.11 (-0.13%)
FB   268.43 (-0.47%)
GOOGL   1,727.56 (-0.51%)
AMZN   3,098.39 (-0.03%)
TSLA   521.85 (+6.58%)
NVDA   525.60 (+0.40%)
BABA   270.11 (-0.23%)
CGC   24.72 (+4.22%)
GE   10.07 (+3.18%)
MU   64.18 (+4.53%)
AMD   85.31 (+0.79%)
T   28.62 (+1.06%)
NIO   55.38 (+12.45%)
F   8.86 (+1.37%)
ACB   7.18 (+0.70%)
GILD   59.89 (-0.37%)
NFLX   476.62 (-2.38%)
BA   211.53 (+5.97%)
DIS   145.98 (+3.48%)
Log in
ASX:OPL

Opyl Limited (OPL.AX) Stock Forecast, Price & News

Add
Compare
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
VolumeN/A
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Opyl Limited operates a SaaS platform that allows to search and source user generated content (UGC). Its UGC Discovery platform protects against unauthorized use of people's social and digital content. The company also offers social media marketing agency services, including client and account management services; a MediaConsent Clinical platform that aggregates structured and unstructured data from various sources giving consumers or patients control over their health data and to contribute their data to medical research; and consumer data and privacy compliance services. It operates in Australia and the United States. The company was formerly known as ShareRoot Limited and changed its name to Opyl Limited in December 2019. Opyl Limited was incorporated in 1994 and is based in St Kilda, Australia.
Read More

Beat the Market (BTM) Rank™

Analyst Opinion: 0.0Community Rank: 0.0Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank™

0.33 out of 5 stars


Industry, Sector and Symbol

Stock Exchange ASX
Industry Health Information Services
Sub-IndustryN/A
SectorMedical
Current SymbolASX:OPL
Previous Symbol
CUSIPN/A
CIKN/A
Webwww.opyl.ai
Phone61 3 9923 1222
EmployeesN/A

Debt

Debt-to-Equity RatioN/A
Current Ratio4.01
Quick Ratio3.98

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$620,783.00
Price / Sales0.00
Cash FlowN/A
Price / Cash FlowN/A
Book ValueA$0.02 per share
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

Outstanding SharesN/A
Market CapN/A
Next Earnings DateN/A
OptionableNot Optionable

Receive OPL News and Ratings via Email

Sign-up to receive the latest news and ratings for OPL and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Opyl Limited (OPL.AX) (ASX:OPL) Frequently Asked Questions

What stocks does MarketBeat like better than Opyl Limited (OPL.AX)?

Wall Street analysts have given Opyl Limited (OPL.AX) a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Opyl Limited (OPL.AX) wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Who are some of Opyl Limited (OPL.AX)'s key competitors?

Some companies that are related to Opyl Limited (OPL.AX) include 1st Group Limited (1ST.AX) (1ST), Alcidion Group Limited (ALC.AX) (ALC), Cann American (CNNA), CannaOne Technologies (CNONF), CB2 Insights (CBIIF), CloudMD Software & Services (DOCRF), CloudMD Software & Services Inc. (DOC.V) (DOC), Cogstate Limited (CGS.AX) (CGS), CompuMed (CMPD), Corum Group Limited (COO.AX) (COO), EGF Theramed Health (EVAHF), Emyria Limited (EMD.AX) (EMD), eWellness Healthcare (EWLL), Global Health Limited (GLH.AX) (GLH) and ICS Global Limited (ICS.AX) (ICS).
View all competitors.

Who are Opyl Limited (OPL.AX)'s key executives?

Opyl Limited (OPL.AX)'s management team includes the following people:
  • Ms. Michelle Gallaher, Chief Exec. Officer
  • Mr. Damon Rasheed, Exec. Director
  • Mr. Shane Lewis, VP of Sales & Partnerships
  • Mr. Scott Sorochak, Chief Revenue Officer
  • Mr. Jason Weaver, Chief Product Officer & Advisor
  • Mr. David Lilja, Company Sec.

What is Opyl Limited (OPL.AX)'s stock symbol?

Opyl Limited (OPL.AX) trades on the ASX under the ticker symbol "OPL."

How big of a company is Opyl Limited (OPL.AX)?

Opyl Limited (OPL.AX) has a market capitalization of $0.00 and generates $620,783.00 in revenue each year.

What is Opyl Limited (OPL.AX)'s official website?

The official website for Opyl Limited (OPL.AX) is www.opyl.ai.

How can I contact Opyl Limited (OPL.AX)?

The company can be reached via phone at 61 3 9923 1222.

This page was last updated on 11/23/2020 by MarketBeat.com Staff
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.